Gene transfer therapy in vascular diseases

Area of Science:

• Cardiovascular Medicine
• Molecular Biology
• Biotechnology

Background:

• Somatic gene therapy is emerging as a promising treatment for vascular diseases.
• Advancements in gene transfer technology enhance understanding of disease genes.
• Genome sequencing facilitates in vivo study of novel gene functions.

Purpose of the Study:

• To review recent advances in somatic gene therapy for vascular diseases.
• To discuss various gene delivery vehicles and their limitations.
• To examine key areas of vascular gene therapy applications.

Main Methods:

• Review of recent scientific literature (primarily last two years) on gene therapy for vascular diseases.
• Discussion of different gene transfer vectors including adenoviruses, retroviruses, plasmids, and oligonucleotides.
• Analysis of six major vascular disease areas: restenosis, thrombosis, hypertension, atherosclerosis, peripheral vascular disease, and heart failure/ischemia.

Main Results:

• Gene transfer enables targeted expression of therapeutic gene products for various vascular conditions.
• Current vectors (adenoviruses, retroviruses, plasmids, etc.) have inherent limitations.
• Ongoing research aims to develop stable, non-immunogenic, and efficiently targeted gene delivery systems.

Conclusions:

• Optimizing gene delivery systems is crucial for clinical application of gene therapy in vascular diseases.
• Gene therapy holds potential for preventing restenosis, thrombosis, hypertension, atherosclerosis, and treating peripheral vascular disease and ischemia.
• Further development of targeted and safe gene transfer methods is essential for advancing vascular disease treatment.